 synergist inhibit verapamil quinin p-glycoprotein-medi multidrug resist human myeloma cell line model effort use approach p-glycoprotein-medi multidrug resist combin chemosensit verapamil quinin multidrug-resist mdr human myeloma cell line model clonogen assay verapamil concentr micrograms/ml plasma level oral administr high-dos intraven IV infus dose quinin constant micrograms/ml plasma concentr oral administr dose level verapamil combin quinin effect drug resist synergist chemosensit interact verapamil microgram/ml quinin capabl sensit resist verapamil micrograms/ml combin mumol verapamil mumol quinin accumul retent anthracyclin resist cell extent drug drug efflux verapamil mumol find combin chemosensit verapamil quinin use patient drug-refractori b-cell neoplasm multipl myeloma non-hodgkin lymphoma